The Viral and Inflammation Hypothesis of Epileptic Seizures Based on Bioinformatic Study of Circulating MiRNAs and Peripheral Whole-blood MRNAs of Adult Epilepsy Patients

Overview

Journal Front Neurol

Specialty Neurology

Date 2022 Sep 29

PMID 36172025

Authors

JiaHuan Wu

Ying Meng

Fei Xu

Qian Wu

Cheng Wang

Affiliations

Soon will be listed here.

Abstract

Background: The study aimed to investigate the genome-wide biological significance of the circulating miRNAs markers found in peripheral whole blood of adult epileptic seizures patients by integrating analysis using bioinformatics approaches.

Methods: The Gene Expression Omnibus (GEO) dataset was accessed to retrieve epilepsy-related circulating miRNA profile data (GSE114847) including 89 subjects ( = 40 epileptic and = 49 healthy control), peripheral whole-blood mRNA expression data (GSE143772) including 64 subjects ( = 32 epileptic and = 32 healthy control). To eliminate age disparities in epilepsy pathophysiology only adult epileptic patients were selected. Furthermore, GEO2R was used to identify adult-related mRNAs (AD-mRNAs) against epilepsy as potential biomarkers. Moreover, to predict the potential target genes for these mRNAs, we used mirWalk. Finally, the Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) were utilized to investigate the biological activities of AD-mRNAs. Importantly, the protein-protein network of these identified AD-mRNAs was constructed. Eventually, the overlapping AD-mRNAs and AD-miRNAs and their functions were explored to shortlist potential AD-epileptic markers.

Result: The current study resulted in the identification of 79 upregulated and 40 downregulated different expression gene (DEGs) in both applied data. These targets were cross-linked and mapped with each other to acquire common adult epilepsy-related overlapped mRNAs (Mo-mRNAs). It was found that there was a total of 36 overlapping genes. These overlapped AD-mRNAs markers were found to be functionally enriched in cell regulating pathways i.e., positive regulation of type 1 interferon signaling pathway and mitochondrial cytochrome C release pathway, respectively.

Conclusion: This research gives a comprehensive depiction of the mRNAs that may be involved in adult epilepsy patients' pathophysiological progressions.

References

He J, Li S, Shu H, Yu S, Liu S, Yin Q . The interleukin 17 system in cortical lesions in focal cortical dysplasias. J Neuropathol Exp Neurol. 2013; 72(2):152-63. DOI: 10.1097/NEN.0b013e318281262e. View

Steinborn B, Zarowski M, Winczewska-Wiktor A, Wojcicka M, Mlodzikowska-Albrecht J, Losy J . Concentration of Il-1β, Il-2, Il-6, TNFα in the blood serum in children with generalized epilepsy treated by valproate. Pharmacol Rep. 2014; 66(6):972-5. DOI: 10.1016/j.pharep.2014.06.005. View

Wouters D, Wagenaar-Bos I, van Ham M, Zeerleder S . C1 inhibitor: just a serine protease inhibitor? New and old considerations on therapeutic applications of C1 inhibitor. Expert Opin Biol Ther. 2008; 8(8):1225-40. DOI: 10.1517/14712598.8.8.1225. View

Khalyfa A, Gaddameedhi S, Crooks E, Zhang C, Li Y, Qiao Z . Circulating Exosomal miRNAs Signal Circadian Misalignment to Peripheral Metabolic Tissues. Int J Mol Sci. 2020; 21(17). PMC: 7503323. DOI: 10.3390/ijms21176396. View

Loscher W, Brandt C . Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research. Pharmacol Rev. 2010; 62(4):668-700. PMC: 3014230. DOI: 10.1124/pr.110.003046. View

Iwakura Y, Ishigame H, Saijo S, Nakae S . Functional specialization of interleukin-17 family members. Immunity. 2011; 34(2):149-62. DOI: 10.1016/j.immuni.2011.02.012. View

Buckinx A, De Bundel D, Kooijman R, Smolders I . Targeting the Ghrelin Receptor as a Novel Therapeutic Option for Epilepsy. Biomedicines. 2022; 10(1). PMC: 8773216. DOI: 10.3390/biomedicines10010053. View

Dolz S, Gorriz D, Tembl J, Sanchez D, Fortea G, Parkhutik V . Circulating MicroRNAs as Novel Biomarkers of Stenosis Progression in Asymptomatic Carotid Stenosis. Stroke. 2016; 48(1):10-16. DOI: 10.1161/STROKEAHA.116.013650. View

Snell L, McGaha T, Brooks D . Type I Interferon in Chronic Virus Infection and Cancer. Trends Immunol. 2017; 38(8):542-557. PMC: 8059441. DOI: 10.1016/j.it.2017.05.005. View

10.

Sunderland N, Skroblin P, Barwari T, Huntley R, Lu R, Joshi A . MicroRNA Biomarkers and Platelet Reactivity: The Clot Thickens. Circ Res. 2017; 120(2):418-435. DOI: 10.1161/CIRCRESAHA.116.309303. View

11.

Wang J, Yu J, Tan L, Tian Y, Ma J, Tan C . Genome-wide circulating microRNA expression profiling indicates biomarkers for epilepsy. Sci Rep. 2015; 5:9522. PMC: 4379481. DOI: 10.1038/srep09522. View

12.

Brennan G, Bauer S, Engel T, Jimenez-Mateos E, Del Gallo F, Hill T . Genome-wide microRNA profiling of plasma from three different animal models identifies biomarkers of temporal lobe epilepsy. Neurobiol Dis. 2020; 144:105048. DOI: 10.1016/j.nbd.2020.105048. View

13.

Kopczynska M, Zelek W, Vespa S, Touchard S, Wardle M, Loveless S . Complement system biomarkers in epilepsy. Seizure. 2018; 60:1-7. DOI: 10.1016/j.seizure.2018.05.016. View

14.

Fu X, Zhang G, Liu Y, Zhang L, Zhang F, Zhou C . Altered expression of the DISC1 gene in peripheral blood of patients with schizophrenia. BMC Med Genet. 2020; 21(1):194. PMC: 7532617. DOI: 10.1186/s12881-020-01132-9. View

15.

Jiang L, Yu X, Ma X, Liu H, Zhou S, Zhou X . Identification of transcription factor-miRNA-lncRNA feed-forward loops in breast cancer subtypes. Comput Biol Chem. 2018; 78:1-7. DOI: 10.1016/j.compbiolchem.2018.11.008. View

16.

Hindorff L, Sethupathy P, Junkins H, Ramos E, Mehta J, Collins F . Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A. 2009; 106(23):9362-7. PMC: 2687147. DOI: 10.1073/pnas.0903103106. View

17.

He J, Wu K, Li S, Shu H, Zhang C, Liu S . Expression of the interleukin 17 in cortical tubers of the tuberous sclerosis complex. J Neuroimmunol. 2013; 262(1-2):85-91. DOI: 10.1016/j.jneuroim.2013.05.007. View

18.

Henshall D, Hamer H, Pasterkamp R, Goldstein D, Kjems J, Prehn J . MicroRNAs in epilepsy: pathophysiology and clinical utility. Lancet Neurol. 2016; 15(13):1368-1376. DOI: 10.1016/S1474-4422(16)30246-0. View

19.

Miossec P, Kolls J . Targeting IL-17 and TH17 cells in chronic inflammation. Nat Rev Drug Discov. 2012; 11(10):763-76. DOI: 10.1038/nrd3794. View

20.

Caserta S, Mengozzi M, Kern F, Newbury S, Ghezzi P, Llewelyn M . Severity of Systemic Inflammatory Response Syndrome Affects the Blood Levels of Circulating Inflammatory-Relevant MicroRNAs. Front Immunol. 2018; 8:1977. PMC: 5807656. DOI: 10.3389/fimmu.2017.01977. View